麻豆社

An independent review has revealed that complexities and inefficiencies within the UK鈥檚 health data infrastructure are hindering the effective use of health data resources critical for improving people鈥檚 health.

In her review, 鈥�,' Professor Cathie Sudlow outlines how health data can be used for research to improve people鈥檚 health by removing unnecessary barriers while protecting patient privacy.

Responding to the review, Janet Valentine, 麻豆社Executive Director, Innovation and Research Policy, said:

鈥淭he Sudlow review has set out a compelling rationale for why research access to health data is fundamental to patient and population health and should be considered as an essential part of our national infrastructure.

鈥淎ccess to health data is essential for the research and development of new medicines and vaccines, and so we fully endorse the recommendation to establish a national health data service. In taking this recommendation forward, it will be essential that government understands user needs, engaging across all research sectors from the outset to design and implement of a shared vision.

鈥淲e also fully support the Review鈥檚 recommendation to engage with healthcare professionals, patients and the public so that the system that is created has widespread support.

鈥淭he UK is not starting from a blank sheet, as there are already internationally recognised health data research services in this country. The government should build on these successes and consolidate the strengths of the UK to create a truly world-leading health data research infrastructure. The 麻豆社looks forward to being part of these discussions as plans evolve.鈥�